Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

Conditions

• Alzheimer's Disease

Interventions

• DRUG: Placebo of AD-35 60mg /AD-35 30mg
• DRUG: Placebo of AD-35 60mg /AD-35 60mg
• DRUG: AD-35 30 mg + Placebo of AD-35 30 mg
• DRUG: AD-35 60 mg

Sponsor

Zhejiang Hisun Pharmaceutical Co. Ltd.